Vanderbilt University Medical Center: New Data Offer Insights on COVID Treatments for People With Cancer
July 23, 2020
July 23, 2020
NASHVILLE, Tennessee, July 23 -- Vanderbilt University Medical Center issued the following news:
Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
The data on 2,186 adults in the United S . . .
Newly released data on treatment outcomes of people with cancer diagnosed with COVID-19 reveal a racial disparity in access to Remdesivir, an antiviral drug that has been shown to shorten hospital stays, and increased mortality associated with dexamethasone, a steroid that has had the opposite effect in the general patient population.
The data on 2,186 adults in the United S . . .